We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GROV icon
1101
Grove Collaborative
GROV
$46.7M
$77.1K ﹤0.01%
67,025
– –
CTNM
1102
Contineum Therapeutics
CTNM
$574M
$76.2K ﹤0.01%
+19,200
New +$83.4K
EDUC icon
1103
Educational Development Corp
EDUC
$11.8M
$74.9K ﹤0.01%
56,300
– –
GUTS icon
1104
Fractyl Health
GUTS
$109M
$73.7K ﹤0.01%
45,500
-20,000
-31% -$32.3K
STTK icon
1105
Shattuck Labs
STTK
$704M
$73.1K ﹤0.01%
92,300
+55,000
+147% +$53.3K
AWRE icon
1106
Aware
AWRE
$27.7M
$72.2K ﹤0.01%
38,400
-25,000
-39% -$41.4K
CULP icon
1107
Culp Inc
CULP
$44.3M
$71.9K ﹤0.01%
18,300
– –
PRLD icon
1108
Prelude Therapeutics
PRLD
$362M
$71.6K ﹤0.01%
88,500
– –
AIRI icon
1109
Air Industries Group
AIRI
$13M
$71.1K ﹤0.01%
21,151
– –
TLYS icon
1110
Tilly's
TLYS
$127M
$70.6K ﹤0.01%
51,159
-36,888
-42% -$50.7K
CABA icon
1111
Cabaletta Bio
CABA
$442M
$69.4K ﹤0.01%
45,675
– –
BSIN
1112
Big Sky Industrial
BSIN
$62.8M
$68.4K ﹤0.01%
48,848
– –
BW icon
1113
Babcock & Wilcox
BW
$1.42B
$68.3K ﹤0.01%
71,000
-161,600
-69% -$110K
OBIO icon
1114
Orchestra BioMed
OBIO
$253M
$67K ﹤0.01%
+25,000
New +$73K
LITS
1115
Lite Strategy Inc
LITS
$32.5M
$66.4K ﹤0.01%
26,869
– –
VNCE icon
1116
Vince Holding Corp
VNCE
$83.9M
$65.2K ﹤0.01%
45,256
– –
MAIA icon
1117
MAIA Biotechnology
MAIA
$85.1M
$64.8K ﹤0.01%
36,000
– –
KRO icon
1118
KRONOS Worldwide
KRO
$714M
$64.1K ﹤0.01%
10,331
-294
-3% -$2.02K
ANTX icon
1119
AN2 Therapeutics
ANTX
$210M
$63.5K ﹤0.01%
59,900
– –
SIF icon
1120
SIFCO Industries
SIF
$169M
$62.2K ﹤0.01%
16,674
– –
MGLD icon
1121
Marygold Companies
MGLD
$45.7M
$62.2K ﹤0.01%
79,767
– –
TVGN icon
1122
Tevogen Inc. Common Stock
TVGN
$28.9M
$61.9K ﹤0.01%
+990
New +$56.4K
NNVC icon
1123
NanoViricides
NNVC
$36.5M
$61.7K ﹤0.01%
44,039
– –
UAMY icon
1124
United States Antimony
UAMY
$945M
$60.6K ﹤0.01%
27,800
– –
OKUR
1125
OnKure Therapeutics
OKUR
$168M
$59.8K ﹤0.01%
25,000
– –
43 44
45
46 47

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.